Silverberg Daniel, Abu Rmeileh Ahmad, Rimon Uri, Raskin Daniel, Halak Moshe
The Department of Vascular Surgery, The Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv, Israel.
The Department of Vascular Surgery, The Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine, Tel Aviv, Israel.
Ann Vasc Surg. 2020 Aug;67:59-66. doi: 10.1016/j.avsg.2020.03.014. Epub 2020 Mar 21.
Primary mycotic aneurysm of the aorta (MAA) is a rare and potentially life-threatening disease. Endovascular aneurysm repair (EVAR) of MAAs involving the paravisceral aorta has been rarely reported. The purpose of this study is to report our experience with chimney EVAR (CHEVAR) in patients with MAAs involving the paravisceral aorta.
We performed a retrospective review of all patients treated with EVAR at our institution during the years 2009-2019. Of those, we identified the patients who were treated with CHEVAR for MAAs. Diagnosis of MAAs was based on clinical presentation, abnormal laboratory results, and a computed tomography scan suggestive of a MAA. The data collected included patient demographics, clinical presentation, the antibiotic regimen before and after the surgery, preoperative imaging, surgical details, and perioperative and long-term morbidity and mortality.
During the study period, we performed 54 cases of CHEVARs for aortic aneurysms. Of those, 8 (15%) were performed for mycotic aneurysms involving the visceral segment. Six (75%) were men, and the mean age was 68 years (range: 59-76). All patients were symptomatic at the time of diagnosis, presenting with either back or abdominal pain. A total of 16 visceral vessels (celiac trunk, 2; superior mesenteric artery, 7; right renal artery, 4; and left renal artery, 3) were revascularized with parallel grafts (PGs). Six patients required 2 PGs, 1 patient required 3 PGs, and 1 patient had a single PG inserted. Fifteen (94%) PGs were upward-pointing chimney stent grafts, and 1 was placed in a downward-pointing "periscope" configuration. Eight visceral arteries in 6 patients were sacrificed, either by preoperative occlusion or intentional coverage with the endograft during the procedure. The vessels sacrificed included 4 celiac trunks and 4 renal arteries (3 main branches and 1 accessory renal artery). Technical success was achieved in all patients. One patient expired in the perioperative period. One patient developed an infection-related complication. One patient experienced worsening of his renal function and eventually required dialysis. Of the 4 patients who underwent intentional sacrifice of a kidney, all experienced a moderate decrease in renal function from the baseline ( mean preoperative and postoperative serum creatinine 0.76 mg/dL and 1.2 mg/dL, respectively, increase of 43%). The mean follow-up was 8 months (range: 3-28 months). During this period, 2 patients expired, 1 from an aneurysm-related cause. No stent occlusion of the PGs occurred and no reintervention due to endoleaks was required. No patient required explanation of the stent grafts or conversion to an open repair.
CHEVAR is a feasible and safe treatment modality for MAAs involving the visceral segment. Occasionally, intentional occlusion of the selected visceral arteries may be required to minimize the risk of gutter endoleaks in this urgent setting. Further follow-up is needed to accurately assess the durability of this repair.
原发性主动脉真菌性动脉瘤(MAA)是一种罕见且可能危及生命的疾病。涉及内脏旁主动脉的MAA的血管腔内动脉瘤修复术(EVAR)鲜有报道。本研究的目的是报告我们对涉及内脏旁主动脉的MAA患者行烟囱式EVAR(CHEVAR)的经验。
我们对2009年至2019年期间在本机构接受EVAR治疗的所有患者进行了回顾性研究。在这些患者中,我们确定了接受CHEVAR治疗MAA的患者。MAA的诊断基于临床表现、异常实验室检查结果以及提示MAA的计算机断层扫描。收集的数据包括患者人口统计学资料、临床表现、手术前后的抗生素治疗方案、术前影像学检查、手术细节以及围手术期和长期的发病率和死亡率。
在研究期间,我们对54例主动脉瘤患者进行了CHEVAR手术。其中,8例(15%)是针对涉及内脏段的真菌性动脉瘤进行的手术。6例(75%)为男性,平均年龄为68岁(范围:59 - 76岁)。所有患者在诊断时均有症状,表现为背部或腹痛。共有16支内脏血管(腹腔干2支;肠系膜上动脉7支;右肾动脉4支;左肾动脉3支)通过平行移植物(PG)进行了血运重建。6例患者需要2个PG,1例患者需要3个PG,1例患者植入了单个PG。15个(94%)PG为向上指向的烟囱式支架移植物,1个以向下指向的“潜望镜”构型放置。6例患者中的8支内脏动脉通过术前闭塞或术中用腔内移植物有意覆盖而被牺牲。被牺牲的血管包括4支腹腔干和4支肾动脉(3支主要分支和1支副肾动脉)。所有患者均取得技术成功。1例患者在围手术期死亡。1例患者发生感染相关并发症。1例患者肾功能恶化,最终需要透析。在4例有意牺牲肾脏的患者中,所有患者的肾功能均较基线水平有中度下降(术前和术后血清肌酐平均分别为0.76 mg/dL和1.2 mg/dL,升高43%)。平均随访时间为8个月(范围:3 - 28个月)。在此期间,2例患者死亡,1例死于与动脉瘤相关的原因。PG未发生支架闭塞,也无需因内漏进行再次干预。没有患者需要取出支架移植物或转为开放修复。
CHEVAR是治疗涉及内脏段MAA的一种可行且安全的治疗方式。在这种紧急情况下,偶尔可能需要有意闭塞选定的内脏动脉,以将肠沟内漏的风险降至最低。需要进一步随访以准确评估这种修复的耐久性。